- Home
- GHG vs ATAI Comparison
GHG vs ATAI Comparison
Compare GHG & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- ATAI
- Stock Information
- Founded
- GHG 2004
- ATAI 2018
- Country
- GHG China
- ATAI Germany
- Employees
- GHG N/A
- ATAI N/A
- Industry
- GHG Hotels/Resorts
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- ATAI Health Care
- Exchange
- GHG Nasdaq
- ATAI Nasdaq
- Market Cap
- GHG 222.9M
- ATAI 282.6M
- IPO Year
- GHG 2018
- ATAI 2021
- Fundamental
- Price
- GHG $2.01
- ATAI $1.41
- Analyst Decision
- GHG
- ATAI Strong Buy
- Analyst Count
- GHG 0
- ATAI 3
- Target Price
- GHG N/A
- ATAI $10.50
- AVG Volume (30 Days)
- GHG 38.3K
- ATAI 1.4M
- Earning Date
- GHG 06-24-2025
- ATAI 05-19-2025
- Dividend Yield
- GHG 4.36%
- ATAI N/A
- EPS Growth
- GHG N/A
- ATAI N/A
- EPS
- GHG 0.15
- ATAI N/A
- Revenue
- GHG $184,055,595.00
- ATAI $308,000.00
- Revenue This Year
- GHG $19.02
- ATAI $65.58
- Revenue Next Year
- GHG $8.26
- ATAI N/A
- P/E Ratio
- GHG $13.14
- ATAI N/A
- Revenue Growth
- GHG N/A
- ATAI N/A
- 52 Week Low
- GHG $1.95
- ATAI $1.03
- 52 Week High
- GHG $3.48
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- GHG 38.07
- ATAI 44.57
- Support Level
- GHG $1.95
- ATAI $1.36
- Resistance Level
- GHG $2.63
- ATAI $1.54
- Average True Range (ATR)
- GHG 0.15
- ATAI 0.09
- MACD
- GHG 0.00
- ATAI -0.00
- Stochastic Oscillator
- GHG 8.82
- ATAI 0.00
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.